Michael Hwang

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 5

Top Topics

Disease Activity

Rheumatoid Arthritis Patients

Top Venues

Clinical pharmacokinetics

British journal of clinical pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Weifeng Tang, Raj Tummala, Joachim Almquist, Michael Hwang, Wendy I White, David W Boulton, Alexander MacDonald
Clinical Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Anifrolumab. Clinical pharmacokinetics 62 (5) (2023)
Weifeng Tang, Raj Tummala, Joachim Almquist, Michael Hwang, Wendy I White, David W Boulton, Alexander MacDonald
Clinical Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Anifrolumab. Clinical pharmacokinetics 62 (5) (2023)
Weifeng Tang, Raj Tummala, Joachim Almquist, Michael Hwang, Wendy I White, David W Boulton, Alexander MacDonald
Clinical Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Anifrolumab. Clinical pharmacokinetics (2023)
Weifeng Tang, Raj Tummala, Joachim Almquist, Michael Hwang, Wendy I White, David W Boulton, Alexander MacDonald
Clinical Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Anifrolumab. Clinical pharmacokinetics 62 (5) (2023)
Michael Hwang, Yen Lin Chia, Yanan Zheng, Cecil Chi-Keung Chen, Jimmy He, Xuyang Song, Diansong Zhou, Sarah B Goldberg, Lillian L Siu, David Planchard, Solange Peters, Helen Mann, Lee Krug, Caroline Even
Population Pharmacokinetic Modeling of Tremelimumab in Patients with Advanced Solid Tumors and the Impact of Disease Status on Time-varying Clearance. British journal of clinical pharmacology (2022)